SCHEMBL4147180

SCHEMBL4147180

COC(=O)c1sc(-c2ccc(-c3cc4nc(C)cc(N)n4n3)cc2)cc1N(C(=O)C1CCC(C)CC1)C(C)C

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 9/20 0.44
HPGD P15428 7/20 0.44
ALDH1A1 P00352 7/20 0.44
RAB9A P51151 6/20 0.44
NPC1 O15118 5/20 0.44
SMN1; SMN2 Q16637 5/20 0.44
PKM P14618 1/20 0.44
CDK5 Q00535 1/20 0.44
CDK5R1 Q15078 1/20 0.44
HTT P42858 3/20 0.39
NFKB1 P19838 1/20 0.39
NFKB2 Q00653 1/20 0.39
RELA Q04206 1/20 0.39
MAPT P10636 6/20 0.38
NPSR1 Q6W5P4 1/20 0.38
LMNA P02545 2/20 0.36
ATM Q13315 2/20 0.35
MEN1 O00255 2/20 0.35
KMT2A Q03164 2/20 0.35
CASP3 P42574 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13852135 1.00 KDM4E (0.44) KDM4EHPGDALDH1A1RAB9ANPC1
SCHEMBL4139468 0.92 HPGD (0.42) KDM4EHPGDALDH1A1RAB9ANPC1
SCHEMBL4139472 0.92 HPGD (0.42) KDM4EHPGDALDH1A1RAB9ANPC1
SCHEMBL13852137 0.89 PDE4D (0.39) KDM4ERAB9ANPC1HTTMAPT
SCHEMBL4148408 0.89 PDE4D (0.39) KDM4ERAB9ANPC1HTTMAPT
SCHEMBL13852136 0.87 KDM4E (0.36) KDM4EHPGDRAB9ANPC1HTT
SCHEMBL4147318 0.87 KDM4E (0.36) KDM4EHPGDRAB9ANPC1HTT
SCHEMBL2427841 0.83 MAPT (0.44) KDM4EHPGDALDH1A1RAB9ANPC1
SCHEMBL2427840 0.83 MAPT (0.44) KDM4EHPGDALDH1A1RAB9ANPC1
SCHEMBL4151930 0.82 NPC1 (0.40) KDM4EHPGDALDH1A1RAB9ANPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090136448-A1 Antiviral 2-Carboxy-Thiophene Compounds CORFIELD JOHN ANDREW 2009-05-28 US disclosed
EP-1971599-A1 ANTIVIRAL 2-CARBOXY-THIOPHENE COMPOUNDS SmithKline Beecham Corporation (US) 2008-09-24 EP disclosed
WO-2007071434-A1 ANTIVIRAL 2-CARBOXY-THIOPHENE COMPOUNDS SMITHKLINE BEECHAM CORPORATION (US) 2007-06-28 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090136448-A1 Antiviral 2-Carboxy-Thiophene Compounds EIF2AK2, HAVCR2, MAVS KDM4E 794/4885HPGD 4655/4885ALDH1A1 1037/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.